Pfizer alum Ying Yang joining Fosun as CBO
Plus Camardo to join Athersys as CEO and updates from NanoDx, Predicine, GenomiCare and more
Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKEX:2196) hired Ying Yang as SVP, CBO. Yang joins the Chinese company after 17 years at Pfizer Inc. (NYSE:PFE), where she held several high-profile positions including VP, WWBD Asia lead; VP, head of strategy and business development; and chief of staff for Greater China. In a LinkedIn post, Yang said that in her new role she would be driving business development deals, overseeing growth of Fosun’s overseas businesses and developing innovative businesses.
Regenerative medicine company Athersys Inc. (NASDAQ:ATHX) named Daniel Camardo as CEO and board member, effective Feb. 14. Camardo is EVP, head of rare disease and inflammation business units, and president at Horizon Therapeutics plc (NASDAQ:HZNP). Interim CEO William Lehmann will continue his previous role as the company’s president and COO...